In summary, these findings suggest that cancer-derived YAP activity contributes to the HAS2/HA/CD44 interaction between CAFs and TAMs and the enhanced interaction of PD-L1 and PD-1 between TAMs and T cells (Figure 5P). The gene discussed is HAS2; the disease is cancer.